Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	DUF1605	DHX16 DHX33 DHX8 DQX1	1.96e-05	17	184	4	IPR011709
Domain	OB_NTP_bind	DHX16 DHX33 DHX8 DQX1	1.96e-05	17	184	4	PF07717
Domain	HA2	DHX16 DHX33 DHX8 DQX1	2.50e-05	18	184	4	SM00847
Domain	HA2	DHX16 DHX33 DHX8 DQX1	2.50e-05	18	184	4	PF04408
Domain	Helicase-assoc_dom	DHX16 DHX33 DHX8 DQX1	2.50e-05	18	184	4	IPR007502
Domain	Ank	ANKK1 ANKRD50 ANKHD1 ANKRD13A SOWAHA RNASEL NFKBIE ANKRD52 ANKS3 ANKRD16	9.07e-05	228	184	10	PF00023
Domain	Limbin/Ellis-van_Creveld	EVC2 EVC	9.65e-05	2	184	2	IPR026501
Domain	ANK	ANKK1 ANKRD50 ANKHD1 ANKRD13A SOWAHA RNASEL NFKBIE ANKRD52 ANKS3 ANKRD16	1.99e-04	251	184	10	SM00248
Domain	ANK_REPEAT	ANKK1 ANKRD50 ANKHD1 ANKRD13A SOWAHA RNASEL NFKBIE ANKRD52 ANKS3 ANKRD16	2.12e-04	253	184	10	PS50088
Domain	Ankyrin_rpt-contain_dom	ANKK1 ANKRD50 ANKHD1 ANKRD13A SOWAHA RNASEL NFKBIE ANKRD52 ANKS3 ANKRD16	2.19e-04	254	184	10	IPR020683
Domain	ANK_REP_REGION	ANKK1 ANKRD50 ANKHD1 ANKRD13A SOWAHA RNASEL NFKBIE ANKRD52 ANKS3 ANKRD16	2.19e-04	254	184	10	PS50297
Domain	Ankyrin_rpt	ANKK1 ANKRD50 ANKHD1 ANKRD13A SOWAHA RNASEL NFKBIE ANKRD52 ANKS3 ANKRD16	2.81e-04	262	184	10	IPR002110
Domain	DJ-1_PfpI	GATD3 GATD1	2.88e-04	3	184	2	PF01965
Domain	DJ-1/PfpI	GATD3 GATD1	2.88e-04	3	184	2	IPR002818
Domain	GPCR_chapero_1	ANKRD13D ANKRD13A	5.72e-04	4	184	2	PF11904
Domain	ANKRD13	ANKRD13D ANKRD13A	5.72e-04	4	184	2	IPR021832
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ANKRD13D LRFN1 ZNF585A GTPBP6 MYO7A KIF26A LAMA5 FRMD8 ANKHD1 TEP1 ABCA7 PIKFYVE DIP2A PIK3CD NBEAL2 CSPG4 MAD1L1 HELZ2 LRP5 SH3BP5L WDR90 TNFAIP2 FUT1 ANKRD16	1.11e-08	1105	191	24	35748872
Pubmed	Comparative Protein Interaction Network Analysis Identifies Shared and Distinct Functions for the Human ROCO Proteins.	ANKRD13D MATK NUDT16L1 SH2D2A ANKRD13A GPBP1L1 BLOC1S5 CCDC149 FCHSD1	5.62e-06	230	191	9	29513927
Pubmed	A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.	PDE8A MAP4K3 VPS13C SYNE1 PPFIA1 FRMD8 DGKD NUDT16L1 SOCS6 ALKBH1 PTPN13 PRCP TMF1 TTC17 SCRIB	1.16e-05	719	191	15	35337019
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	MPP1 DCHS2 MAP2 MYO7A PPFIA1 COPS3 DIP2A TAOK3 NBEAL2 NID1 MYOM2 EIF2AK4	2.19e-05	497	191	12	36774506
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	DCHS2 GATD3 RELN GTPBP6 PEG10 SYNE1 KIF1B POLR2C ACTN4 CMYA5 GFPT1 SPTBN4 DIP2A GUF1 PTPN13 KRT222 GPSM2 TTC17 SCRIB SMYD3	2.97e-05	1285	191	20	35914814
Pubmed	Evc2 is a positive modulator of Hedgehog signalling that interacts with Evc at the cilia membrane and is also found in the nucleus.	EVC2 EVC	3.00e-05	2	191	2	21356043
Pubmed	Mutations in two nonhomologous genes in a head-to-head configuration cause Ellis-van Creveld syndrome.	EVC2 EVC	3.00e-05	2	191	2	12571802
Pubmed	The fucose salvage pathway inhibits invadopodia formation and extracellular matrix degradation in melanoma cells.	FCSK FUT1	3.00e-05	2	191	2	29924834
Pubmed	Novel homozygous mutations in the EVC and EVC2 genes in two consanguineous families segregating autosomal recessive Ellis-van Creveld syndrome.	EVC2 EVC	3.00e-05	2	191	2	26580685
Pubmed	Widening the mutation spectrum of EVC and EVC2: ectopic expression of Weyer variants in NIH 3T3 fibroblasts disrupts Hedgehog signaling.	EVC2 EVC	3.00e-05	2	191	2	19810119
Pubmed	Modulation of tau tubulin kinases (TTBK1 and TTBK2) impacts ciliogenesis.	TTBK2 TTBK1	3.00e-05	2	191	2	37059819
Pubmed	Expression of MCSP and PRAME in conjunctival melanoma.	CSPG4 PRAME	3.00e-05	2	191	2	20805128
Pubmed	ANKHD1 is required for SMYD3 to promote tumor metastasis in hepatocellular carcinoma.	ANKHD1 SMYD3	3.00e-05	2	191	2	30646949
Pubmed	Iron-inhibited autophagy via transcription factor ZFP27 in Parkinson's disease.	ZNF585A ZNF585B	3.00e-05	2	191	2	37668106
Pubmed	Sequencing EVC and EVC2 identifies mutations in two-thirds of Ellis-van Creveld syndrome patients.	EVC2 EVC	3.00e-05	2	191	2	17024374
Pubmed	Pathological phosphorylation of tau and TDP-43 by TTBK1 and TTBK2 drives neurodegeneration.	TTBK2 TTBK1	3.00e-05	2	191	2	29409526
Pubmed	Mechanisms of Regulation and Diverse Activities of Tau-Tubulin Kinase (TTBK) Isoforms.	TTBK2 TTBK1	3.00e-05	2	191	2	32424773
Pubmed	Increased glutamine catabolism mediates bone anabolism in response to WNT signaling.	LRP5 EIF2AK4	3.00e-05	2	191	2	25562323
Pubmed	Ellis-van Creveld syndrome: prenatal diagnosis, molecular analysis and genetic counseling.	EVC2 EVC	3.00e-05	2	191	2	21199751
Pubmed	Novel mutations in EVC cause aberrant splicing in Ellis-van Creveld syndrome.	EVC2 EVC	3.00e-05	2	191	2	26621368
Pubmed	Kinesin superfamily motor protein KIF17 and mLin-10 in NMDA receptor-containing vesicle transport.	LIN7C MAP2 LIN7A	3.46e-05	12	191	3	10846156
Pubmed	Deletion of Shp2 in the brain leads to defective proliferation and differentiation in neural stem cells and early postnatal lethality.	RELN MAP2 CSPG4	3.46e-05	12	191	3	17646384
Pubmed	Enhanced prediction of Src homology 2 (SH2) domain binding potentials using a fluorescence polarization-derived c-Met, c-Kit, ErbB, and androgen receptor interactome.	MATK SH2D3C GRB7 SH2D2A SOCS6	5.26e-05	73	191	5	24728074
Pubmed	Smooth muscle-endothelial cell communication activates Reelin signaling and regulates lymphatic vessel formation.	RELN LAMA5 CSPG4	5.68e-05	14	191	3	22665518
Pubmed	Comprehensive binary interaction mapping of SH2 domains via fluorescence polarization reveals novel functional diversification of ErbB receptors.	MATK SH2D3C GRB7 SH2D2A SOCS6	6.80e-05	77	191	5	22973453
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	EDF1 MAP4K3 VPS13C FPGS KIF1B HAUS5 ACTN4 GFPT1 KLHL22 CEP250 NFKBIE TTC17 POC5 ANKRD52 FHIP2B	8.15e-05	853	191	15	28718761
Pubmed	The Amot/Patj/Syx signaling complex spatially controls RhoA GTPase activity in migrating endothelial cells.	LIN7C LIN7A PTPN13	8.66e-05	16	191	3	18824598
Pubmed	ADAMTS18 Deficiency Affects Neuronal Morphogenesis and Reduces the Levels of Depression-like Behaviors in Mice.	MAP2 LAMA5 ADAMTS16	8.66e-05	16	191	3	30579834
Pubmed	Enlarged lateral ventricles and aberrant behavior in mice overexpressing PDGF-B in embryonic neural stem cells.	PDGFA MAP2 CSPG4	8.66e-05	16	191	3	20643125
Pubmed	Myosin VIIA is specifically associated with calmodulin and microtubule-associated protein-2B (MAP-2B).	MAP2 MYO7A	8.97e-05	3	191	2	11171103
Pubmed	Ellis-van Creveld syndrome and profound deafness resulted by sequence variants in the EVC/EVC2 and TMC1 genes.	EVC2 EVC	8.97e-05	3	191	2	29321360
Pubmed	Genomic organization and complete nucleotide sequence of the human PWP2 gene on chromosome 21.	GATD3 TRAPPC10	8.97e-05	3	191	2	9205129
Pubmed	The avian influenza virus NS1 ESEV PDZ binding motif associates with Dlg1 and Scribble to disrupt cellular tight junctions.	LIN7C SCRIB	8.97e-05	3	191	2	21849460
Pubmed	Tau-tubulin kinase 1 (TTBK1), a neuron-specific tau kinase candidate, is involved in tau phosphorylation and aggregation.	TTBK2 TTBK1	8.97e-05	3	191	2	16923168
Pubmed	Smoothened transduces Hedgehog signal by forming a complex with Evc/Evc2.	EVC2 EVC	8.97e-05	3	191	2	22986504
Pubmed	Cytochrome b5 and epoxide hydrolase contribute to benzo[a]pyrene-DNA adduct formation catalyzed by cytochrome P450 1A1 under low NADPH:P450 oxidoreductase conditions.	CYP1A1 CYB5R4	8.97e-05	3	191	2	24530354
Pubmed	The tau tubulin kinases TTBK1/2 promote accumulation of pathological TDP-43.	TTBK2 TTBK1	8.97e-05	3	191	2	25473830
Pubmed	Truncation and microdeletion of EVC/EVC2 with missense mutation of EFCAB7 in Ellis-van Creveld syndrome.	EVC2 EVC	8.97e-05	3	191	2	26748586
Pubmed	Isolation of cDNA for a novel human protein KNP-I that is homologous to the E. coli SCRP-27A protein from the autoimmune polyglandular disease type I (APECED) region of chromosome 21q22.3.	GATD3 TRAPPC10	8.97e-05	3	191	2	8753807
Pubmed	Association of DNA polymerase mu (pol mu) with Ku and ligase IV: role for pol mu in end-joining double-strand break repair.	POLM LIG4	8.97e-05	3	191	2	12077346
Pubmed	Transcriptional Regulation of PIK3CD and PIKFYVE in T-Cell Acute Lymphoblastic Leukemia by IKAROS and Protein Kinase CK2.	PIKFYVE PIK3CD	8.97e-05	3	191	2	33467550
Pubmed	Disruption of hippocampal development in vivo by CR-50 mAb against reelin.	RELN MAP2	8.97e-05	3	191	2	9223338
Pubmed	Methylation Status of Transcriptional Modulatory Genes Associated with Colorectal Cancer in Northeast China.	CA10 CSPG4	8.97e-05	3	191	2	29291617
Pubmed	Taking the next step forward - Diagnosing inherited infantile cholestatic disorders with next generation sequencing.	PKHD1 ABCB11	8.97e-05	3	191	2	25771912
Pubmed	LIN7 regulates the filopodium- and neurite-promoting activity of IRSp53.	LIN7C LIN7A	8.97e-05	3	191	2	22767515
Pubmed	Impaired plasma membrane localization of ubiquitin ligase complex underlies 3-M syndrome development.	MAP2 MYO7A CANX LAMA5 MIDEAS EMILIN1 TBL3 GFPT1 TTBK1 FER1L4 PHLDB2	1.03e-04	496	191	11	31343991
Pubmed	Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics.	LAMA5 EMILIN1 MMRN1 LMAN1L CSPG4 NID1	1.06e-04	135	191	6	28675934
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	MAP4K3 PPFIA1 AKNAD1 ACTN4 NUDT16L1 ANKRD50 ANKHD1 TTBK2 AREL1 TAOK3 PTPN13 PIK3CD TRAPPC10 EIF2AK4 DEDD DSE FHIP2B	1.10e-04	1084	191	17	11544199
Pubmed	Identification of substrates of SMURF1 ubiquitin ligase activity utilizing protein microarrays.	ANKRD13D MATK ANKRD50 ANKRD13A TAOK3	1.22e-04	87	191	5	20804422
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	PPFIA1 POLR2C HAUS5 RNF213 ANKHD1 TEP1 ABCA7 PHF21A YEATS2 FCSK SOWAHA ASPM TEKT1 SCRIB ANKRD52 ANKS3 PHLDB2	1.55e-04	1116	191	17	31753913
Pubmed	Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.	AKNAD1 RNF213 YEATS2 PKHD1 CARD11 EIF2AK4 SCRIB	1.61e-04	208	191	7	33230847
Pubmed	Extracellular matrix remodelling in response to venous hypertension: proteomics of human varicose veins.	LAMA5 EMILIN1 SERPINA4 RNPEP CSPG4 NID1	1.63e-04	146	191	6	27068509
Pubmed	CASK deletion in intestinal epithelia causes mislocalization of LIN7C and the DLG1/Scrib polarity complex without affecting cell polarity.	LIN7C LIN7A SCRIB	1.74e-04	20	191	3	19726564
Pubmed	EFCAB7 and IQCE regulate hedgehog signaling by tethering the EVC-EVC2 complex to the base of primary cilia.	EVC2 EVC	1.79e-04	4	191	2	24582806
Pubmed	Long interspersed nuclear element-1 (LINE1)-mediated deletion of EVC, EVC2, C4orf6, and STK32B in Ellis-van Creveld syndrome with borderline intelligence.	EVC2 EVC	1.79e-04	4	191	2	18454448
Pubmed	BDNF regulates reelin expression and Cajal-Retzius cell development in the cerebral cortex.	RELN MAP2	1.79e-04	4	191	2	9728912
Pubmed	Facilitation of dendritic mRNA transport by CPEB.	MAP2 KIF1B	1.79e-04	4	191	2	12629046
Pubmed	Renal defects associated with improper polarization of the CRB and DLG polarity complexes in MALS-3 knockout mice.	LIN7C LIN7A	1.79e-04	4	191	2	17923534
Pubmed	TMF/ARA160 is a BC-box-containing protein that mediates the degradation of Stat3.	ELOC TMF1	1.79e-04	4	191	2	15467733
Pubmed	Association study of brain-derived neurotrophic factor (BDNF) and LIN-7 homolog (LIN-7) genes with adult attention-deficit/hyperactivity disorder.	LIN7C LIN7A	1.79e-04	4	191	2	18286632
Pubmed	Cajal-Retzius cells and subplate neurons differentially express vesicular glutamate transporters 1 and 2 during development of mouse cortex.	RELN MAP2	1.79e-04	4	191	2	17651422
Pubmed	MALS is a binding partner of IRSp53 at cell-cell contacts.	LIN7C LIN7A	1.79e-04	4	191	2	14596909
Pubmed	Structure and chromosomal localization of mouse G protein subunit gamma 4 gene.	LAMA5 NID1	1.79e-04	4	191	2	9570961
Pubmed	The reeler gene-associated antigen on Cajal-Retzius neurons is a crucial molecule for laminar organization of cortical neurons.	RELN MAP2	1.79e-04	4	191	2	7748558
Pubmed	The Asymmetric Cell Division Regulators Par3, Scribble and Pins/Gpsm2 Are Not Essential for Erythroid Development or Enucleation.	GPSM2 SCRIB	1.79e-04	4	191	2	28095473
Pubmed	Liprin-α1, ERC1 and LL5 define polarized and dynamic structures that are implicated in cell migration.	PPFIA1 PHLDB2	1.79e-04	4	191	2	24982445
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	KIF26A VPS13C HAUS5 LAMA5 ANKRD50 ANKHD1 PHF21A NBEAL2 WDR90 EIF2AK4 ANKS3	1.80e-04	529	191	11	14621295
Pubmed	Sequence organization and matrix attachment regions of the human serine protease inhibitor gene cluster at 14q32.1.	CCDC197 PPP4R4 SERPINA4	2.02e-04	21	191	3	15014966
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	MPP1 CHERP DPH7 VPS13C PPFIA1 RNF213 DHX8 PIKFYVE YEATS2 TMF1 TTC17 SH3BP5L POC5	2.25e-04	733	191	13	34672954
Pubmed	DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation.	SYNE1 ANKHD1 SPTBN4	2.32e-04	22	191	3	12812986
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	MYO7A VPS13C CANX TBC1D2 RNF213 SH2D2A GFPT1 DIP2A MROH8 DQX1 PKHD1 SCRIB DSE	2.34e-04	736	191	13	29676528
Pubmed	Prediction of the coding sequences of unidentified human genes. XIX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	SYNE1 PHF21A HELZ2 CFAP74 SH3BP5L	2.57e-04	102	191	5	11214970
Pubmed	Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma.	MPP1 LIN7C PPFIA1 ANKRD50 DIP2A TAOK3 PTPN13 CSPG4 SCRIB	2.57e-04	377	191	9	38117590
Pubmed	TNF-alpha regulates mouse fetal hepatic maturation induced by oncostatin M and extracellular matrices.	CPS1 ABCB11	2.97e-04	5	191	2	15349890
Pubmed	A critical function of the pial basement membrane in cortical histogenesis.	RELN NID1	2.97e-04	5	191	2	12122064
Pubmed	Disabled-1 acts downstream of Reelin in a signaling pathway that controls laminar organization in the mammalian brain.	RELN MAP2	2.97e-04	5	191	2	9716537
Pubmed	Analysis of Ellis van Creveld syndrome gene products: implications for cardiovascular development and disease.	EVC2 EVC	2.97e-04	5	191	2	19251731
Pubmed	Characterization of MALS/Velis-1, -2, and -3: a family of mammalian LIN-7 homologs enriched at brain synapses in association with the postsynaptic density-95/NMDA receptor postsynaptic complex.	LIN7C LIN7A	2.97e-04	5	191	2	10341223
Pubmed	The stardust family protein MPP7 forms a tripartite complex with LIN7 and DLG1 that regulates the stability and localization of DLG1 to cell junctions.	LIN7C LIN7A	2.97e-04	5	191	2	17237226
Pubmed	Contrasting localizations of MALS/LIN-7 PDZ proteins in brain and molecular compensation in knockout mice.	LIN7C LIN7A	2.97e-04	5	191	2	11104771
Pubmed	The Ankrd13 Family of Ubiquitin-interacting Motif-bearing Proteins Regulates Valosin-containing Protein/p97 Protein-mediated Lysosomal Trafficking of Caveolin 1.	ANKRD13D ANKRD13A	2.97e-04	5	191	2	26797118
Pubmed	Splicing variations in the ligand-binding domain of ApoER2 results in functional differences in the binding properties to Reelin.	RELN MAP2	2.97e-04	5	191	2	19167437
Pubmed	The E3 ubiquitin ligase HOIL-1 induces the polyubiquitination and degradation of SOCS6 associated proteins.	ELOC SOCS6	2.97e-04	5	191	2	16643902
Pubmed	C3G regulates cortical neuron migration, preplate splitting and radial glial cell attachment.	RELN MAP2	2.97e-04	5	191	2	18506028
Pubmed	Complete sequence, recombinant analysis and binding to laminins and sulphated ligands of the N-terminal domains of laminin alpha3B and alpha5 chains.	LAMA5 NID1	2.97e-04	5	191	2	11829758
Pubmed	CFEOM1-associated kinesin KIF21A is a cortical microtubule growth inhibitor.	PPFIA1 PHLDB2	2.97e-04	5	191	2	24120883
Pubmed	Requirement for early-generated neurons recognized by monoclonal antibody lot1 in the formation of lateral olfactory tract.	RELN MAP2	2.97e-04	5	191	2	9742149
Pubmed	Identification of a novel brain-specific and Reelin-regulated gene that encodes a protein colocalized with synapsin.	RELN MAP2	2.97e-04	5	191	2	15255972
Pubmed	Gamma protocadherins are required for survival of spinal interneurons.	RELN MAP2 PCDHA11	3.86e-04	26	191	3	12467588
Pubmed	Structural basis for c-KIT inhibition by the suppressor of cytokine signaling 6 (SOCS6) ubiquitin ligase.	ELOC SOCS6	4.44e-04	6	191	2	21030588
Pubmed	Close homolog of L1 modulates area-specific neuronal positioning and dendrite orientation in the cerebral cortex.	RELN MAP2	4.44e-04	6	191	2	15504324
Pubmed	A unified assembly mode revealed by the structures of tetrameric L27 domain complexes formed by mLin-2/mLin-7 and Patj/Pals1 scaffold proteins.	LIN7C LIN7A	4.44e-04	6	191	2	15863617
Pubmed	Molecular cloning and characterization of Pals, proteins associated with mLin-7.	LIN7C LIN7A	4.44e-04	6	191	2	10753959
Pubmed	Polysialic acid as an antigen for monoclonal antibody HIgM12 to treat multiple sclerosis and other neurodegenerative disorders.	MAP2 CSPG4	4.44e-04	6	191	2	25866077
Pubmed	Genetic, personality, and environmental predictors of drug use in adolescents.	GABRB3 ANKK1	4.44e-04	6	191	2	19717274
Pubmed	LPIAT1 regulates arachidonic acid content in phosphatidylinositol and is required for cortical lamination in mice.	RELN MAP2	4.44e-04	6	191	2	23097495
Pubmed	Role of presenilin-1 in cortical lamination and survival of Cajal-Retzius neurons.	RELN MAP2	4.44e-04	6	191	2	15617678
Pubmed	Collapsin response mediator protein 1 mediates reelin signaling in cortical neuronal migration.	RELN MAP2	4.44e-04	6	191	2	17182786
Pubmed	The Ankrd 13 family of UIM-bearing proteins regulates EGF receptor endocytosis from the plasma membrane.	ANKRD13D ANKRD13A	4.44e-04	6	191	2	22298428
Pubmed	Overlapping, complementary and site-specific expression pattern of genes of the EMILIN/Multimerin family.	EMILIN1 MMRN1	4.44e-04	6	191	2	14996434
Cytoband	7p22	PDGFA MAD1L1 CHST12 CARD11	1.34e-06	20	191	4	7p22
Cytoband	Ensembl 112 genes in cytogenetic band chr15q24	CYP1A1 MAN2C1 HCN4 LMAN1L CSPG4	1.65e-04	122	191	5	chr15q24
Cytoband	20q13.2-q13.3	LAMA5 CHRNA4	1.71e-04	5	191	2	20q13.2-q13.3
Cytoband	15q24.1	CYP1A1 HCN4 LMAN1L	3.86e-04	34	191	3	15q24.1
Cytoband	20q11.22	MROH8 FER1L4 CEP250	4.96e-04	37	191	3	20q11.22
Cytoband	Ensembl 112 genes in cytogenetic band chr2q34	MAP2 CPS1 PIKFYVE	8.84e-04	45	191	3	chr2q34
Cytoband	1p36.2	KIF1B PIK3CD	1.30e-03	13	191	2	1p36.2
GeneFamily	Ankyrin repeat domain containing	ANKRD13D ANKK1 ANKRD50 ANKHD1 ANKRD13A SOWAHA RNASEL NFKBIE ANKRD52 ANKS3 ANKRD16	1.03e-06	242	126	11	403
GeneFamily	DEAH-box helicases	DHX16 DHX33 DHX8	1.73e-04	16	126	3	500
GeneFamily	Sterile alpha motif domain containing	PPFIA1 DGKD BFAR SASH3 ANKS3	3.75e-04	88	126	5	760
GeneFamily	PDZ domain containing	MPP1 LIN7C LIN7A PTPN13 CARD11 SCRIB	6.88e-04	152	126	6	1220
GeneFamily	SH2 domain containing	MATK SH2D3C GRB7 SH2D2A SOCS6	7.05e-04	101	126	5	741
GeneFamily	EMI domain containing	EMILIN1 MMRN1	9.89e-04	7	126	2	540
GeneFamily	Zinc fingers MYND-type\|A-kinase anchoring proteins	MAP2 MYO7A CMYA5	1.06e-03	29	126	3	396
GeneFamily	PDZ domain containing\|Crumbs complex	LIN7C LIN7A	1.68e-03	9	126	2	1223
ToppCell	3'_v3-Lung-Lymphocytic_NK-NK_CD16\|Lung / Manually curated celltypes from each tissue	MATK SYNE1 SH2D2A NCR3 DIP2A FCRL3 TRAPPC10 CHST12 CARD11 MYOM2	1.26e-08	194	191	10	3337042eef91a49f621058785723228cf4dfdad4
ToppCell	severe-NK\|severe / disease stage, cell group and cell class	MATK SYNE1 RNF213 SH2D2A NCR3 DIP2A FCRL3 CHST12 CARD11 MYOM2	1.52e-08	198	191	10	cb505077dc5bdf3fdd513bb9032e32bb9644c004
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MATK SYNE1 RNF213 SH2D2A NCR3 DIP2A FCRL3 CHST12 CARD11 MYOM2	1.60e-08	199	191	10	eb05ccae5187e4701bbbe6d714a6d2808fbcf306
ToppCell	Sepsis-URO-Lymphocyte-T/NK-NK\|URO / Disease, condition lineage and cell class	MATK SYNE1 RNF213 SH2D2A NCR3 DIP2A FCRL3 CHST12 CARD11 MYOM2	1.68e-08	200	191	10	741c7bad606c7e4d7db57d89aaf4dcf4232fa82a
ToppCell	COPD-Lymphoid-NK\|COPD / Disease state, Lineage and Cell class	MATK SYNE1 SH2D2A NCR3 DIP2A FCRL3 CHST12 CARD11 MYOM2	1.28e-07	188	191	9	c9a227c8e71b69929d43e9afb8306a95c8163778
ToppCell	(2)_NK/T-(210)_NKT_cell\|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization)	MATK SH2D2A NCR3 DIP2A SASH3 CHST12 MYOM2 ANKRD52 ANKS3	1.34e-07	189	191	9	fa72e87e1e8cd7cbddae7b47e19cf90d181820a7
ToppCell	(2)_NK/T-(21)_NKT_cell\|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization)	MATK SH2D2A NCR3 DIP2A SASH3 CHST12 MYOM2 ANKRD52 ANKS3	1.34e-07	189	191	9	b37ad24898a14a4a3b2d6cea2637de2471f76e20
ToppCell	3'_v3-bone_marrow-Lymphocytic_NK\|bone_marrow / Manually curated celltypes from each tissue	MATK SYNE1 RNF213 SH2D2A NCR3 DIP2A FCRL3 CHST12 MYOM2	1.60e-07	193	191	9	e790ab76c12f74a13936c231076f1e397283efb3
ToppCell	3'_v3-bone_marrow-Lymphocytic_NK-NK_CD16\|bone_marrow / Manually curated celltypes from each tissue	MATK SYNE1 RNF213 SH2D2A NCR3 DIP2A FCRL3 CHST12 MYOM2	1.68e-07	194	191	9	7773501e076d470158dbc1d7f10c67152b326eb7
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MATK SYNE1 ACTN4 SH2D2A NCR3 DIP2A FCRL3 SASH3 CARD11	1.68e-07	194	191	9	ae5357e2a276473cde1fc8c43acaf9f69da35fd7
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-innate_lymphocytic\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MATK SYNE1 ACTN4 SH2D2A NCR3 DIP2A FCRL3 SASH3 CARD11	1.68e-07	194	191	9	3a0b8b5d0354c43da57bb951cd8ba878363c3de5
ToppCell	10x5'-bone_marrow-Lymphocytic_NK\|bone_marrow / Manually curated celltypes from each tissue	MATK SYNE1 ACTN4 SH2D2A NCR3 DIP2A CHST12 CARD11 MYOM2	1.83e-07	196	191	9	1868ad537b7f04cdad0a0c8282aadbc4f257a722
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PDGFA MAP2 TBC1D2 LAMA5 LIN7A YEATS2 NBEAL2 CENATAC PHLDB2	1.91e-07	197	191	9	8d5097898dd01cedb04cb694cb480c931e08462c
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_NK-NK_dim\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	MATK SYNE1 RNF213 ACTN4 SH2D2A NCR3 DIP2A CHST12 MYOM2	1.91e-07	197	191	9	4e141dfb094e10383d815fc7108b11a0584c3a4b
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_NK-NK_dim-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	MATK SYNE1 RNF213 ACTN4 SH2D2A NCR3 DIP2A CHST12 MYOM2	1.91e-07	197	191	9	08286770c0b707a7a4436ea8d4416ddfbfe2dc0c
ToppCell	healthy_donor-Lymphocytic-ILC-NK_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	MATK SYNE1 RNF213 ACTN4 SH2D2A NCR3 DIP2A CARD11 MYOM2	1.99e-07	198	191	9	d7053a898e04478c577381085f615edaad3cdc5b
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MATK SYNE1 SH2D2A NCR3 DIP2A FCRL3 CHST12 CARD11 MYOM2	1.99e-07	198	191	9	c54da37aa11f82a68e591d563b3db9121d6b498f
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-innate_lymphocytic\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MATK SYNE1 SH2D2A NCR3 DIP2A FCRL3 CHST12 CARD11 MYOM2	1.99e-07	198	191	9	90023468f3498548a92d75928f476b4157bde813
ToppCell	remission-NK\|World / disease stage, cell group and cell class	MATK SYNE1 RNF213 ACTN4 SH2D2A NCR3 DIP2A SASH3 CHST12	1.99e-07	198	191	9	383ed78164ad37826100d3de6c3cc14f62e01813
ToppCell	URO-Lymphocyte-T_NK-NK\|URO / Disease, Lineage and Cell Type	MATK SYNE1 RNF213 SH2D2A NCR3 DIP2A FCRL3 CHST12 MYOM2	1.99e-07	198	191	9	2ccff882aafabf041df15b31d9abc50dcbc2696e
ToppCell	severe_COVID-19-NK\|World / disease group, cell group and cell class (v2)	MATK SYNE1 RNF213 SH2D2A NCR3 DIP2A CHST12 CARD11 MYOM2	1.99e-07	198	191	9	36b1370ef68c4bbe0268933a6ef5e6022d992bdf
ToppCell	healthy_donor-Lymphocytic-ILC\|healthy_donor / Disease condition, Lineage, Cell class and subclass	MATK SYNE1 RNF213 ACTN4 SH2D2A NCR3 DIP2A CARD11 MYOM2	1.99e-07	198	191	9	aa33be29e26f1b8facfc894413099083ae3bbb1b
ToppCell	PBMC-Convalescent-Lymphocyte-T/NK-NK_cell-NK\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MATK SYNE1 RNF213 ACTN4 SH2D2A NCR3 DIP2A SASH3 CHST12	2.08e-07	199	191	9	fd3706f256e33cf348774bea0ba0df6d41fd96e3
ToppCell	PBMC-Convalescent-Lymphocyte-T/NK-NK_cell-NK-\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MATK SYNE1 RNF213 ACTN4 SH2D2A NCR3 DIP2A SASH3 CHST12	2.08e-07	199	191	9	252f0084fa17770f4c34e21066519d7f7cad75d9
ToppCell	PBMC-Convalescent-Lymphocyte-T/NK-NK_cell-NK-\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MATK SYNE1 RNF213 ACTN4 SH2D2A NCR3 DIP2A SASH3 CHST12	2.08e-07	199	191	9	e981b159841222a6838effff1059c683c20ecf5b
ToppCell	COVID_non-vent-Lymphocytic-ILC\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	MATK SYNE1 RNF213 SH2D2A NCR3 DIP2A FCRL3 CARD11 MYOM2	2.08e-07	199	191	9	df4f7d5be099e3e6054f3b812ccf70251664e4c0
ToppCell	PBMC-Convalescent-Lymphocyte-T/NK-NK_cell\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MATK SYNE1 RNF213 ACTN4 SH2D2A NCR3 DIP2A SASH3 CHST12	2.08e-07	199	191	9	8cdd5aa30a8112b77f5d02b40c45b63f541e1476
ToppCell	COVID-19_Convalescent-Lymphoid_T/NK-NK\|COVID-19_Convalescent / Disease group, lineage and cell class	MATK SYNE1 RNF213 ACTN4 SH2D2A NCR3 DIP2A SASH3 CHST12	2.08e-07	199	191	9	9809d996a2c3f5384707646a3929e1d6b85dcdc2
ToppCell	PBMC-Convalescent-Lymphocyte-T/NK-NK_cell\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MATK SYNE1 RNF213 ACTN4 SH2D2A NCR3 DIP2A SASH3 CHST12	2.08e-07	199	191	9	a2ac6af5e8e13e7edd3302ebdb175a3902bfb2bc
ToppCell	remission-NK\|remission / disease stage, cell group and cell class	MATK SYNE1 RNF213 ACTN4 SH2D2A NCR3 DIP2A SASH3 CHST12	2.08e-07	199	191	9	31ed2a314e8f70980ea0686242446d66929288e9
ToppCell	COVID_non-vent-Lymphocytic-ILC-NK_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	MATK SYNE1 RNF213 SH2D2A NCR3 DIP2A FCRL3 CARD11 MYOM2	2.08e-07	199	191	9	ed35d747f11f6ea6a5cb7061057f0a98d9e0db99
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MATK SYNE1 RNF213 SH2D2A NCR3 DIP2A FCRL3 CHST12 MYOM2	2.08e-07	199	191	9	4820f5bcd7bc34c2ebf6a3422cc8eb383a3b5a4e
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	MATK SYNE1 RNF213 SH2D2A NCR3 DIP2A FCRL3 CHST12 MYOM2	2.08e-07	199	191	9	10c8729b779073c3bf808e85958d59147f0be5c5
ToppCell	PBMC-Convalescent-Lymphocyte-T/NK-NK_cell-NK\|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09)	MATK SYNE1 RNF213 ACTN4 SH2D2A NCR3 DIP2A SASH3 CHST12	2.08e-07	199	191	9	899642ff6bb6c1612f14a9a049b4344ae694752a
ToppCell	Control-NK\|Control / Disease condition and Cell class	MATK SYNE1 RNF213 ACTN4 NCR3 DIP2A FCRL3 CHST12 MYOM2	2.08e-07	199	191	9	f3316fb97c6065286ffd22a0ad9fe7aa5b3b5650
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MATK SYNE1 RNF213 SH2D2A NCR3 DIP2A FCRL3 CHST12 MYOM2	2.08e-07	199	191	9	867fd292f3879982422e840e087bfdb3b21a8715
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MATK SYNE1 RNF213 SH2D2A NCR3 DIP2A FCRL3 CHST12 MYOM2	2.08e-07	199	191	9	5e9fe852a70546c9d235414a2c26ca3e67ba6eb9
ToppCell	Control-Lymphoid_T/NK-NK\|Control / Disease group, lineage and cell class	MATK SYNE1 RNF213 SH2D2A NCR3 DIP2A FCRL3 CHST12 MYOM2	2.08e-07	199	191	9	94b2693a8378b9b2c58c6aebb2c6658d75b2e3de
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	MATK SYNE1 RNF213 SH2D2A NCR3 DIP2A FCRL3 CHST12 MYOM2	2.08e-07	199	191	9	d2c9fb69e5ef75778a1652da293fcf8cfa7ecfcc
ToppCell	Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MATK SH2D2A NCR3 DIP2A FCRL3 SASH3 PIK3CD CARD11 MYOM2	2.17e-07	200	191	9	7d90fcb5dfc4c9d562c93b0f9293ed12b5f4f404
ToppCell	COVID-19-COVID-19_Convalescent-Lymphocyte-T/NK-NK\|COVID-19_Convalescent / Disease, condition lineage and cell class	MATK SYNE1 RNF213 ACTN4 SH2D2A NCR3 DIP2A SASH3 CHST12	2.17e-07	200	191	9	50d844683dcfe35e59fffa0c23f1532d692d0c17
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-NK\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MATK SYNE1 SH2D2A NCR3 DIP2A FCRL3 SASH3 CARD11 MYOM2	2.17e-07	200	191	9	0a6fc7eff94e2f71af9f31a01779aafd2f4a6699
ToppCell	COVID-19_Convalescent-NK\|COVID-19_Convalescent / Disease condition and Cell class	MATK SYNE1 RNF213 ACTN4 SH2D2A NCR3 DIP2A SASH3 CHST12	2.17e-07	200	191	9	dd62477b12c54065d4b70866c1523e9c217a48a9
ToppCell	severe-NK\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MATK SYNE1 RNF213 ACTN4 SH2D2A NCR3 TRAPPC10 CHST12 MYOM2	2.17e-07	200	191	9	d6767f06fe13be8110a86c2a6029be2dd9ce666c
ToppCell	Severe-Lymphoid-NK-CD8_T\|Severe / Condition, Lineage, Cell class and cell subclass	MATK SYNE1 SH2D2A NCR3 FCRL3 PIK3CD CHST12 CARD11	6.48e-07	167	191	8	8d41015871616ab7eced5104cd8f70d0efe504f2
ToppCell	5'-Adult-Appendix-Hematopoietic-T_cells-NK_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MATK SYNE1 RNF213 SH2D2A NCR3 CHST12 CARD11 FCHSD1	8.10e-07	172	191	8	f3c16a62eba1ed190318beee131c71c5150b266a
ToppCell	mild_COVID-19_(asymptomatic)-gd_T\|World / disease group, cell group and cell class (v2)	MATK SYNE1 SH2D2A NCR3 SPTBN4 CHST12 MYOM2 WNK3	8.46e-07	173	191	8	b6615ff02f5017d7150b1e33b53f8c7a26081a0d
ToppCell	5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LRFN1 MATK SH2D2A NCR3 FCRL3 TRAPPC10 CARD11 MYOM2	8.84e-07	174	191	8	7ebf06076946729c1af25109df6066731097c3b1
ToppCell	5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LRFN1 MATK SH2D2A NCR3 FCRL3 TRAPPC10 CARD11 MYOM2	8.84e-07	174	191	8	90961e8839514985712b8b986aec3391bb249ba7
ToppCell	5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LRFN1 MATK SH2D2A NCR3 FCRL3 TRAPPC10 CARD11 MYOM2	8.84e-07	174	191	8	c4b0987d9394f977fe6bc6a4214a6d8d73d0abcc
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-brain_pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO7A LAMA5 EMILIN1 CCDC149 CSPG4 WDR90 CENATAC PHLDB2	1.40e-06	185	191	8	38486b69c48dc5e1c4e1488208fa8954a973eccb
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO7A LAMA5 EMILIN1 CCDC149 CSPG4 WDR90 CENATAC PHLDB2	1.40e-06	185	191	8	3c28b5ceba3cfdb6f7e32d5b42e03b6a81a7a658
ToppCell	10x5'v1-week_12-13-Lymphocytic_NK-T_NK-mature_NK\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	MATK SYNE1 RNF213 SH2D2A NCR3 FCRL3 CHST12 MYOM2	1.46e-06	186	191	8	165d02be3b3eaeb8784a2b0b2020928b21a19bc7
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_C\|390C / Donor, Lineage, Cell class and subclass (all cells)	MATK RNF213 NCR3 DIP2A FCRL3 SASH3 CHST12 MYOM2	1.52e-06	187	191	8	1e8651e6c547384ace5a66b96c6b24a7f390a7ee
ToppCell	COPD-Lymphoid-NK\|World / Disease state, Lineage and Cell class	SYNE1 SH2D2A NCR3 DIP2A FCRL3 CHST12 CARD11 MYOM2	1.64e-06	189	191	8	c0ac160fa7e68b92414fb1600abcac8ad1a42232
ToppCell	IPF-Lymphoid-NK\|IPF / Disease state, Lineage and Cell class	SYNE1 SH2D2A NCR3 DIP2A FCRL3 CHST12 CARD11 MYOM2	1.64e-06	189	191	8	d92e880162450f8d01e4b8784eb625275cb8e03e
ToppCell	Control-Lymphoid-NK\|Lymphoid / Disease state, Lineage and Cell class	MATK DGKD NCR3 DIP2A FCRL3 CHST12 CARD11 MYOM2	1.71e-06	190	191	8	1584c68b58c7f406d9b0e8451beea3e6f8980c56
ToppCell	Control-Lymphoid-NK\|Control / Disease state, Lineage and Cell class	MATK SYNE1 SH2D2A NCR3 DIP2A FCRL3 CARD11 MYOM2	1.71e-06	190	191	8	f7bd8521a40ac30a64dc439f17e2f6c7d021ef65
ToppCell	IPF-Lymphoid-NK\|Lymphoid / Disease state, Lineage and Cell class	MATK SYNE1 NCR3 DIP2A FCRL3 CHST12 CARD11 MYOM2	1.78e-06	191	191	8	f2ddc0962007d7a4e78fbd916ebb62fc557d480a
ToppCell	IPF-Lymphoid-NK\|World / Disease state, Lineage and Cell class	SYNE1 SH2D2A NCR3 DIP2A FCRL3 CHST12 CARD11 MYOM2	1.78e-06	191	191	8	f206159b9d5e84cf14a65bfdc008895cec5a8081
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MATK SYNE1 ACTN4 SH2D2A NCR3 FCRL3 CHST12 MYOM2	1.85e-06	192	191	8	ce867b6e78c1d8f30dff81bf572a78a897bc7625
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MATK SYNE1 ACTN4 SH2D2A NCR3 FCRL3 CHST12 MYOM2	1.85e-06	192	191	8	58a7829b411b02b422ef75e2277a868969cc23e8
ToppCell	3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MATK SH2D2A NCR3 DIP2A FCRL3 CHST12 CARD11 MYOM2	1.85e-06	192	191	8	1922b0350d3375e67c314dbce8074e5cf986f2ef
ToppCell	3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MATK SH2D2A NCR3 DIP2A FCRL3 CHST12 CARD11 MYOM2	1.85e-06	192	191	8	97c197643e59835c6d45dde9e549c9a1b1bb7288
ToppCell	3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MATK SH2D2A NCR3 DIP2A FCRL3 CHST12 CARD11 MYOM2	1.85e-06	192	191	8	a4d161e3d48bc020e687808b352325ef9d1cc1f3
ToppCell	nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-NK\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MATK SH2D2A NCR3 DIP2A FCRL3 CHST12 CARD11 MYOM2	1.85e-06	192	191	8	a06d5d3c2537f8d2b1dc6b6f3e88a80b5c2a1850
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MATK SYNE1 ACTN4 SH2D2A NCR3 CHST12 CARD11 MYOM2	1.92e-06	193	191	8	54604c2c5dce2ff6f3ec7ca82b595b09b8cdafe8
ToppCell	background-NK_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	MATK SH3KBP1 SH2D2A NCR3 SASH3 CHST12 CARD11 MYOM2	1.92e-06	193	191	8	f8d6eff1e04926f85d265ec39fe66897fe29574d
ToppCell	COPD-Lymphoid-NK\|Lymphoid / Disease state, Lineage and Cell class	SYNE1 NCR3 DIP2A FCRL3 TRAPPC10 CHST12 CARD11 MYOM2	1.92e-06	193	191	8	0020249fa71afb500af73700543bb6f349be6b10
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-innate_lymphocytic\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MATK SYNE1 SH2D2A NCR3 DIP2A FCRL3 ASPM CHST12	2.00e-06	194	191	8	8bfd7c5be518b81b17913139bcb3ebea01f48dd5
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MATK SH2D2A NCR3 FCRL3 SASH3 CHST12 CARD11 MYOM2	2.00e-06	194	191	8	fa72c2f3e6b8bfc2ef126deb219ec6a44809385b
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MATK SYNE1 SH2D2A NCR3 DIP2A FCRL3 ASPM CHST12	2.00e-06	194	191	8	f0707601883b234ed477c7704ca9a88efaefc3fd
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MATK SH2D2A NCR3 FCRL3 SASH3 CHST12 CARD11 MYOM2	2.00e-06	194	191	8	bc7c4efe2a82057fb95582da983e36f413990902
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MATK SH2D2A NCR3 FCRL3 SASH3 CHST12 CARD11 MYOM2	2.00e-06	194	191	8	b43788e458a80ab93f485f4577370aec448ad95e
ToppCell	3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MATK SH2D2A NCR3 DIP2A FCRL3 CHST12 CARD11 MYOM2	2.08e-06	195	191	8	e1b7ef4ba2ab14d3c839b6305d91efcfd0826220
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_NK\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	MATK SYNE1 RNF213 SH2D2A NCR3 DIP2A CHST12 MYOM2	2.08e-06	195	191	8	609732e83ab7fc3ba7dace66f5a17e46557fd6d1
ToppCell	3'-Distal_airway-Immune_Lymphocytic\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MATK SH2D2A NCR3 DIP2A FCRL3 CHST12 CARD11 MYOM2	2.08e-06	195	191	8	4a60b51f92830882872f2fe1a911db2970faf071
ToppCell	wk_20-22-Hematologic_Lymphocytic-NK-CD16+_NK\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	MATK RNF213 SH2D2A NCR3 FCRL3 SASH3 CHST12 MYOM2	2.08e-06	195	191	8	7533822d2fe551f499b5b2fdec7172f56c79cb44
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_NK-NK_CD16\|lymph-node_spleen / Manually curated celltypes from each tissue	MATK SYNE1 SH2D2A NCR3 DIP2A FCRL3 CHST12 MYOM2	2.08e-06	195	191	8	e756733cf48768bf40058d6cf9039e52f7563133
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_dim-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	MATK SYNE1 RNF213 SH2D2A NCR3 DIP2A CHST12 MYOM2	2.16e-06	196	191	8	5b5cf6f70534661d694f47359b6595b4580876c3
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_dim\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	MATK SYNE1 RNF213 SH2D2A NCR3 DIP2A CHST12 MYOM2	2.16e-06	196	191	8	8e1ed30256a031bb90dac1f167e074c68efbed74
ToppCell	10x5'-bone_marrow-Lymphocytic_NK-NK_CD16\|bone_marrow / Manually curated celltypes from each tissue	MATK SYNE1 SH2D2A NCR3 DIP2A CHST12 CARD11 MYOM2	2.16e-06	196	191	8	a3b077e82b1550eb328c84b567b60179001f9a77
ToppCell	background-NK_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	MATK SH2D2A CCDC88B NCR3 FCRL3 SASH3 CARD11 MYOM2	2.24e-06	197	191	8	e8e1d3e557fe821efe81012e759e35e4ae33ce86
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MPP1 MATK SOCS6 MPIG6B CCDC88B LMAN1L SASH3 MARCHF3	2.24e-06	197	191	8	b597c292fc1cb381a4325fed15a32966c38def28
ToppCell	Severe-Lymphoid-NK-NK\|Severe / Condition, Lineage, Cell class and cell subclass	MATK SYNE1 SH2D2A NCR3 DIP2A FCRL3 CHST12 CARD11	2.24e-06	197	191	8	d5b94f9f73e9d050245841b19b046242a32c6258
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MATK SYNE1 SH2D2A NCR3 FCRL3 CHST12 CARD11 MYOM2	2.24e-06	197	191	8	bc37b8919f98dc18c2200834405f06823d965d78
ToppCell	COVID-19_Moderate-CD8+_T_activated\|COVID-19_Moderate / disease group, cell group and cell class	MATK SYNE1 RNF213 SH2D2A NCR3 HELZ2 CHST12 MYOM2	2.24e-06	197	191	8	4711ecb157e907758a5021248ae8b043d17672c6
ToppCell	COVID-19_Severe-NK_activated\|World / disease group, cell group and cell class	MATK SYNE1 RNF213 SH2D2A NCR3 DIP2A CHST12 MYOM2	2.24e-06	197	191	8	a60db36d1a192998e3ded63e0c7c08d41689f95f
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MATK RNF213 ACTN4 SH2D2A NCR3 DIP2A SASH3 MYOM2	2.24e-06	197	191	8	b6689a3e01e4c285fc2cb33f8c437078722a3892
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MATK SYNE1 RNF213 SH2D2A NCR3 FCRL3 CHST12 MYOM2	2.33e-06	198	191	8	a1b310274aa9b3d2aa1fe9488d67422bf4ac81d2
ToppCell	severe_COVID-19-NK\|severe_COVID-19 / disease group, cell group and cell class (v2)	MATK SYNE1 RNF213 SH2D2A NCR3 DIP2A CHST12 MYOM2	2.33e-06	198	191	8	7f51e37516f717e424190e6584f1c74d357e2da4
ToppCell	PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MATK SYNE1 RNF213 SH2D2A NCR3 DIP2A CHST12 MYOM2	2.33e-06	198	191	8	0e918e9db9b884f5328d438e90efe065e27266ee
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	MATK SYNE1 ACTN4 SH2D2A NCR3 DIP2A TRAPPC10 MYOM2	2.33e-06	198	191	8	faeef749a4b4bdc7f3edb6923e0e248e8b92c9d0
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MATK SYNE1 RNF213 SH2D2A NCR3 FCRL3 CHST12 MYOM2	2.33e-06	198	191	8	76aff381403bc5a8a9cc73eb1e5dbdc0bac7de6c
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MATK SYNE1 SH2D2A NCR3 DIP2A CHST12 MYOM2 PHLDB2	2.33e-06	198	191	8	2fdb92b198ba24e326e90479fd024400d956fb32
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MATK RNF213 ACTN4 SH2D2A NCR3 DIP2A SASH3 MYOM2	2.33e-06	198	191	8	1a189b2b213099505c5d871fb8aedd55a97d44e0
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	MATK SYNE1 RNF213 SH2D2A NCR3 FCRL3 CHST12 MYOM2	2.33e-06	198	191	8	a781fd35a7cda8b7760c2e3ddccaac7aac26c979
ToppCell	PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MATK SYNE1 RNF213 SH2D2A NCR3 DIP2A CHST12 MYOM2	2.33e-06	198	191	8	ce92d5fbc2eac27fb246b044fb1914ab92506275
ToppCell	Healthy-NK\|World / disease group, cell group and cell class	MATK SYNE1 SH2D2A NCR3 DIP2A FCRL3 CHST12 MYOM2	2.33e-06	198	191	8	517e49669e13e428aa66081a0ce83c30f3b9b08b
ToppCell	PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	MATK SYNE1 RNF213 SH2D2A NCR3 DIP2A CHST12 MYOM2	2.33e-06	198	191	8	fed823d6e684d113bcc9ff3cd1803bb001aa02fa
Disease	Ellis-van Creveld syndrome	EVC2 EVC	3.70e-05	2	180	2	cv:C0013903
Disease	ELLIS-VAN CREVELD SYNDROME	EVC2 EVC	3.70e-05	2	180	2	225500
Disease	Ellis-Van Creveld syndrome (implicated_via_orthology)	EVC2 EVC	3.70e-05	2	180	2	DOID:12714 (implicated_via_orthology)
Disease	Weyers acrofacial dysostosis (is_implicated_in)	EVC2 EVC	3.70e-05	2	180	2	DOID:0111571 (is_implicated_in)
Disease	WEYERS ACROFACIAL DYSOSTOSIS	EVC2 EVC	3.70e-05	2	180	2	193530
Disease	Curry-Hall syndrome	EVC2 EVC	3.70e-05	2	180	2	cv:C0457013
Disease	Weyers acrofacial dysostosis	EVC2 EVC	3.70e-05	2	180	2	C0457013
Disease	Large cell carcinoma of lung	ANKK1 TTBK1 NIM1K WNK3	4.21e-05	32	180	4	C0345958
Disease	apolipoprotein B measurement	DCHS2 AKNAD1 PKD2L1 MIDEAS PPP4R4 LMAN1L FER1L4 CYP26C1 ABCB11 GPSM2 POC5 FUT1 PMFBP1 OSGIN1	6.10e-05	663	180	14	EFO_0004615
Disease	Ellis-Van Creveld syndrome (is_implicated_in)	EVC2 EVC	1.11e-04	3	180	2	DOID:12714 (is_implicated_in)
Disease	Ellis-Van Creveld Syndrome	EVC2 EVC	2.20e-04	4	180	2	C0013903
Disease	mosaic variegated aneuploidy syndrome (is_implicated_in)	MAD1L1 CENATAC	2.20e-04	4	180	2	DOID:0080688 (is_implicated_in)
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	ELOC GRB7 SPTBN4 CARD11 PRAME WNK3	3.05e-04	148	180	6	C0279702
Disease	fasting blood glucose measurement, glucose tolerance test, fasting blood insulin measurement	VPS13C ABCB11	3.66e-04	5	180	2	EFO_0004307, EFO_0004465, EFO_0004466
Disease	venous thromboembolism, fibrinogen measurement	DCHS2 CPS1 TTC17 PMFBP1	7.61e-04	67	180	4	EFO_0004286, EFO_0004623
Disease	Squamous cell carcinoma of lung	ANKK1 MAP4K3 WNK3	9.72e-04	32	180	3	C0149782
Disease	perceived unattractiveness to mosquitos measurement	LAMA5 NYX DHX8 NID1	9.97e-04	72	180	4	EFO_0008380
Disease	Sarcomatoid Renal Cell Carcinoma	ELOC GRB7 SPTBN4 CARD11 PRAME	1.15e-03	128	180	5	C1266043
Disease	Chromophobe Renal Cell Carcinoma	ELOC GRB7 SPTBN4 CARD11 PRAME	1.15e-03	128	180	5	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	ELOC GRB7 SPTBN4 CARD11 PRAME	1.15e-03	128	180	5	C1266044
Disease	Papillary Renal Cell Carcinoma	ELOC GRB7 SPTBN4 CARD11 PRAME	1.15e-03	128	180	5	C1306837
Disease	Renal Cell Carcinoma	ELOC GRB7 SPTBN4 CARD11 PRAME	1.15e-03	128	180	5	C0007134
Disease	2R,3R-dihydroxybutyrate measurement	ELOC CPS1	1.30e-03	9	180	2	EFO_0800314
Disease	decadienedioic acid (C10:2-DC) measurement	PKD2L1 MIDEAS	1.61e-03	10	180	2	EFO_0800598
Disease	Lewy body dementia	DHX8 MMRN1 CYB5R4	1.74e-03	39	180	3	EFO_0006792
Disease	Combined immunodeficiency	LIG4 PIK3CD CARD11	2.01e-03	41	180	3	C0494261
Disease	low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	PKD2L1 PPP4R4 FCSK ABCB11 PMFBP1	2.53e-03	153	180	5	EFO_0004611, EFO_0020946
Disease	albuminuria	CYP1A1 CPS1 FUT1 FBXL20	2.66e-03	94	180	4	EFO_0004285
Disease	esophageal cancer (is_implicated_in)	CYP1A1 IL1R2	2.76e-03	13	180	2	DOID:5041 (is_implicated_in)
Disease	male infertility (implicated_via_orthology)	ADAMTS16 PMFBP1	2.76e-03	13	180	2	DOID:12336 (implicated_via_orthology)
Disease	autosomal dominant polycystic kidney disease (implicated_via_orthology)	PKD2L1 LRP5	3.21e-03	14	180	2	DOID:898 (implicated_via_orthology)
Disease	attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia	SYNE1 LIG4 IL1R2 MAD1L1	3.45e-03	101	180	4	EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090
Disease	Opioid use measurement	LIN7A MYOM2	3.69e-03	15	180	2	EFO_0009937
Disease	obesity	DGKD FXN CMYA5 PKHD1 CARD11 POC5	3.73e-03	241	180	6	EFO_0001073
Disease	Heschl's gyrus morphology measurement	CCDC149 MYOM2 DSE	4.18e-03	53	180	3	EFO_0005852
Disease	cholesteryl ester 16:1 measurement	PKD2L1 SMYD3	4.20e-03	16	180	2	EFO_0010342
Disease	Ciliopathies	EVC2 MYO7A EVC PKHD1	4.68e-03	110	180	4	C4277690
Disease	urate measurement, bone density	SYNE1 TBC1D2 LAMA5 DGKD DHX33 CA10 ADAMTS16 HELZ2 EIF2AK4 CYB5R4	4.89e-03	619	180	10	EFO_0003923, EFO_0004531
Disease	urinary albumin to creatinine ratio	CYP1A1 LIN7C CPS1 FUT1 FBXL20	4.93e-03	179	180	5	EFO_0007778
Disease	protein Z-dependent protease inhibitor measurement	PPP4R4 SERPINA4	5.31e-03	18	180	2	EFO_0021849
Disease	calcium measurement	MAP4K3 DGKD SH2D2A CPS1 PPP4R4 KCNK6 EIF2AK4 FBXL20 FHIP2B OSGIN1	5.39e-03	628	180	10	EFO_0004838
Disease	prostate cancer (is_implicated_in)	CYP1A1 LIG4 RNASEL MAD1L1	5.82e-03	117	180	4	DOID:10283 (is_implicated_in)
Disease	Lewy body dementia (is_marker_for)	MAP2 CHRNA4	5.91e-03	19	180	2	DOID:12217 (is_marker_for)

Protein segments in the cluster

Peptide	Gene	Start	Entry
SFLTEHERIHTGEKL	ZNF354C	481	Q86Y25
LDEHALVELELHRGS	CATSPERZ	86	Q9NTU4
ASSHVETRAHAEERL	CHRNA4	26	P43681
HDRQVVHVETLGLTL	ANKRD13D	191	Q6ZTN6
DRSLADVIIHEISHS	RNPEP	316	Q9H4A4
GHIDVARLLLDEHGA	ANKRD16	216	Q6P6B7
SAHLIIKDLGEIHSR	BLOC1S5	31	Q8TDH9
TRLGEAHAELDSLRH	CCDC88B	396	A6NC98
HLDTNLDIRSGDEVH	CSPG4	1151	Q6UVK1
HLDTVLGALDVQEHS	COPS3	41	Q9UNS2
DILVEHISGVSLAAH	EIF2AK4	376	Q9P2K8
VEHLRGLSDHVSLDG	SH3BP5L	351	Q7L8J4
STLGIHVDRSELDHS	ALKBH1	226	Q13686
HLAARHGEEAVVSAL	ANKK1	631	Q8NFD2
LLGGILEEVHSHSTI	GJA10	6	Q969M2
IVHTIEEIEGLISAH	ACTN4	556	O43707
HGTAVERGTHEELLE	ABCB11	631	O95342
VDSRVALRIHEHAAI	BTBD11	221	A6QL63
ASAPVHEIHESALRA	CCSAP	206	Q6IQ19
ALEGHRDIVELLFSH	ANKRD50	921	Q9ULJ7
DIVGTHLTHRDVRVL	DEDD	31	O75618
LSHGATVLAVDEEGH	ANKRD52	981	Q8NB46
VQDELHSVLGLSERH	DHX16	11	O60231
EAHERTLHTDILFGL	DHX16	521	O60231
VHRSLESLEEDHRAL	CCDC197	106	Q8NCU1
EHGNTILSKDIVDRH	ASPM	1026	Q8IZT6
DGTRHDHAILLTGLD	ADAMTS16	376	Q8TE57
HHLDEAELLGDRVAV	ABCA7	996	Q8IZY2
HHNTGLSEALEILAE	POLM	151	Q9NP87
GHIRDITDSLIEHCQ	CYP1A1	276	P04798
HVDHGKSTLADRLLE	GUF1	76	Q8N442
FRHVSDLHGLTELIL	KCNK6	256	Q9Y257
IDEHLHTKDFLTRIG	C8orf48	231	Q96LL4
HLAVSLGHLESARVL	ANKRD13A	46	Q8IZ07
TGASIHLARELELHD	EXO5	116	Q9H790
SHDGVSLHELLAAEL	FXN	176	Q16595
HSSVHLEEAGILRAG	PCDHA11	816	Q9Y5I1
DVRISTIHDILHSQG	POC5	61	Q8NA72
DDRHIISGSEDHTLV	FBXW9	316	Q5XUX1
LKSVEEELHQRGHVA	MAP4K3	396	Q8IVH8
QEGAVDTFTLIHHEL	KIAA0100	1746	Q14667
HHDLTLARTIGDQLG	GPSM2	86	P81274
VSVEGEHHEKAVELL	LIN7A	161	O14910
VSVEGEHHEKAVELL	LIN7C	146	Q9NUP9
VLHRDGHLTIDEAVF	MATK	171	P42679
HEHTEILTVSGELLF	MCTS2	56	A0A3B3IRV3
EFSHTVGELIEVHLR	MAD1L1	681	Q9Y6D9
AELHIRDVRGHDASI	NCR3	91	O14931
DVAHSDLILHVRDVS	GTPBP6	371	O43824
EDSEIAFHLRVHLGR	LGALS16	46	A8MUM7
LHLDATLDAVLVSHA	MSS51	196	Q4VC12
GLEAREHLLHVTVVL	LRIT2	456	A6NDA9
EEGEVLSHSLEAEHR	GPBP1L1	376	Q9HC44
THLEGALEQEHSRSI	MMRN1	486	Q13201
ISLEGVHVIDSREKH	FRMD8	296	Q9BZ67
RPTIESHHVAISDAE	CAMKK1	106	Q8N5S9
RQDIVLSGAHIKEEH	KIF1B	566	O60333
HHGDAILGLEEVRLT	LMAN1L	56	Q9HAT1
LTLDHNLIDHIAEGT	LRFN1	191	Q9P244
SEDGDTLVHLAVIHE	NFKBIE	256	O00221
GLITVDIALAADHHS	KIAA1109	1076	Q2LD37
DGTEIHEASAILVHL	GATD3B	56	A0A0B4J2D5
HDLVGSDDLIGETHI	FER1L4	1321	A9Z1Z3
AHLTGIHAVEEVSLE	LRP5	1196	O75197
EELHHDRVTLEVGKV	EDF1	66	O60869
HLITEAHTVVADALA	FHIP2B	351	Q86V87
SLHAVERGLENSLHA	KRT222	71	Q8N1A0
DREEATAHHLVLTAS	PCDHGA9	201	Q9Y5G4
EVAALIAATIHDVDH	PDE8A	586	O60658
DEHGHLTIDTELEGR	NID1	541	P14543
SLGLVTHDHLEEIQS	PHF21A	371	Q96BD5
THDLIVDLGDHREVL	PEG10	416	Q86TG7
VAVTISEGAHHLDLR	PRCP	446	P42785
LALLDSATERHVDHA	EVC2	1156	Q86UK5
KGALHTVSHEDIRDI	PPFIA1	756	Q13136
ASSHEHIAARLTEAV	DSE	61	Q9UL01
VEAAHRLAGHASLER	KIF26A	1426	Q9ULI4
VDAHGNILLTSLEVH	GABRB3	361	P28472
GHVLAALEHLAAERE	HAUS5	241	O94927
HLAVFHLDSEASVRL	LAMA5	1161	O15230
EEAAEGIHSLLHITL	MROH8	271	Q9H579
EVKSTLEHLGITEEH	NIM1K	356	Q8IY84
RRALEHTDGDHSSLI	DQX1	516	Q8TE96
HLALERGLEDHESVV	GRB7	151	Q14451
HLHDSAEERRLIAEG	HCN4	121	Q9Y3Q4
HLAEIHSDSIILRDD	RELN	191	P78509
HSLDREASASHELVI	DCHS2	2621	Q6V1P9
ELEAAEVILEHAHRG	FCHSD1	256	Q86WN1
VVGTEALIHAVLHLE	FCSK	861	Q8N0W3
SASEPDAVHVVLDRH	GATD1	181	Q8NB37
HELVSTRIAEHLGDS	PIKFYVE	1131	Q9Y2I7
RVISHAISEHVEDAG	CPS1	1186	P31327
EVRVVLVALDHAGLH	FER1L6-AS2	21	Q96M78
DVVLVVEGRHIEAHR	KLHL22	51	Q53GT1
SRESEHDLLVHKAVA	BFAR	166	Q9NZS9
LELEGTVSRHGDLTH	BORCS6	201	Q96GS4
HILSGHENRIIDVDA	CCDC149	146	Q6ZUS6
LAEGVSHVIIGEDHS	LIG4	856	P49917
ITADGAHFELRLHLI	CHERP	201	Q8IWX8
REHILATGSYDEHIL	DPH7	251	Q9BTV6
DSLLHAHLSGADVVV	FCGBP	3366	Q9Y6R7
LDSLLHAHLSGADVV	FCGBP	4566	Q9Y6R7
VLVSKHHLEAAEDTR	CMYA5	2866	Q8N3K9
IHDLESHSTVLAREL	CEP250	1611	Q9BV73
LVLGTAIVEAHDGHD	CANX	11	P27824
AHERTIHTDVLFGVV	DHX33	196	Q9H6R0
VHIHQELLTGIESEA	AKNAD1	336	Q5T1N1
EAHDTVDLTSVLRHV	ADPRS	41	Q9NX46
VGLRVHISHVELAVE	AREL1	96	O15033
ALDLIIHSARELGHE	CYP26C1	266	Q6V0L0
LISSDGHEFIVKREH	ELOC	21	Q15369
RAHTVVGDLLELHCE	FCRL3	391	Q96P31
VDHLHFSSRLEAVGL	MARCHF3	171	Q86UD3
FIALLVEEGHTHDIL	MANEAL	301	Q5VSG8
SLVLRLYEAHGSHVD	MAN2C1	971	Q9NTJ4
ALHCLHESRGDILET	MIDEAS	791	Q6PJG2
DEIHLELTAEHLSRA	HUS1B	76	Q8NHY5
HDTIVHLLLEAGVSV	ANKS3	81	Q6ZW76
FTRHDIRGSELLHLE	DGKD	1166	Q16760
DGTEIHEASAILVHL	GATD3	56	P0DPI2
HSGASILREAAAIHV	FPGS	551	Q05932
CEVREHLSHGNLTVL	CENATAC	71	Q86UT8
HRQGSLHVGDEILEI	MPP1	106	Q00013
LLDTRVSTHDQELGH	EMILIN1	246	Q9Y6C2
SSVLQTHLREDHEGT	EVC	601	P57679
TTALAGLEAHTHIDL	DIP2A	206	Q14689
HVQGHERSLLVSTDE	HELZ2	2471	Q9BYK8
HRLEEIRLHFGSEDS	CA10	126	Q9NS85
TLHELLERIGLEEHT	SASH3	256	O75995
EEVDGTHHTLRALRN	CARD11	856	Q9BXL7
LVGVEEHLRDFIHVD	CFAP74	551	Q9C0B2
EAHERTIHTDVLFGL	DHX8	686	Q14562
HHELSALEAATRVGA	OSGIN1	266	Q9UJX0
SLEGVSHHAAIEILQ	PTPN13	1151	Q12923
HGADRHEVISKEILE	KBTBD12	561	Q3ZCT8
HAHLERGRIEAVASS	NYX	186	Q9GZU5
SSETHVNLEHLRIDV	FBXL21P	251	Q9UKT6
DLHGLREETSAHIER	PMFBP1	356	Q8TBY8
TLHDHLREEAQSVLG	FUT1	186	P19526
QVILLHLEHRDTGVS	PPP4R4	136	Q6NUP7
ESYEDIHGTLHLERL	PRAME	446	P78395
HVVLGEDSAHARLQD	SH2D2A	151	Q9NP31
VALTRHKDHAAEVES	SYNE1	1801	Q8NF91
SEAEDHTRALHRLIA	SYNE1	2781	Q8NF91
LEGDAHTHETTLRDL	SYNE1	3521	Q8NF91
LDIEFDVHLGIAHTR	GFPT1	81	Q06210
LIGSSSHVEREDAVH	NBPF9	511	P0DPF3
ELSESDVHRGFQHLL	SERPINA4	111	P29622
SLSHCELITDDGIRH	FBXL20	331	Q96IG2
LEALVGAVHVLHASR	NBEAL2	251	Q6ZNJ1
RHEDESRTVLHVLGD	MPIG6B	111	O95866
KEEHISLAHRGVDAS	SH3KBP1	516	Q96B97
SDVEAITHLLLDHGA	RNASEL	216	Q05823
KRIGIDLVHDTVEHE	TEKT1	121	Q969V4
EVEIAAITHGALHGL	TAOK3	121	Q9H2K8
HVTEDGRHIRLAAEV	PKHD1	2936	P08F94
HTTELHVLDVAGNRL	SCRIB	356	Q14160
VDVTEARHDHAVSLL	SCRIB	921	Q14160
VAGLSEEASAELRHH	HRC	46	P23327
LIHIGLSHEVQEDFS	CYB5R4	216	Q7L1T6
DLRSHVETAGHNIDT	PHLDB2	1121	Q86SQ0
VRGTTHLLVHDVALE	IL1R2	186	P27930
RVTHGREHSLIEDLI	SMYD3	401	Q9H7B4
SSVLHDEFIAHRLGL	POLR2C	56	P19387
ASAGHVEVARVLLDH	ANKHD1	346	Q8IWZ3
NSELSHLIVDDRHGA	CHST12	151	Q9NRB3
GTHVLVSAAHEARVE	TGDS	121	O95455
LGHSADETIGVVHLV	RNF213	4631	Q63HN8
TVHIDHLVVERSDDG	UHRF1BP1L	1341	A0JNW5
EEEVKSSLHESLHIG	TMF1	126	P82094
AILDVLHRHSKDDSG	USP51	456	Q70EK9
RLDGHCHSELAIDII	TNFAIP2	351	Q03169
LEAAEVLVEHTCHRG	WDR90	771	Q96KV7
SIEAIHSVGFLHRDI	TTBK1	141	Q5TCY1
HVVAAHLELGLVSRL	TEP1	1566	Q99973
EDSLDTSLRAHGVHA	PDGFA	56	P04085
LAALHGHEDAAVLLV	SOWAHA	391	Q2M3V2
EISAVHSRDHGLEVL	NUDT16L1	126	Q9BRJ7
ILHGHTDIVLALDVF	TBL3	371	Q12788
TRRLGATIDVEHSHV	RRAGA	36	Q7L523
LESIESIHSVGFLHR	TTBK2	126	Q6IQ55
LSTHVEIGHRALEFL	GPLD1	26	P80108
NSDLSIHEKIHTGER	ZNF585B	226	Q52M93
ILELGRHSECVHVTE	PIK3CD	491	O00329
ESAEHEAAHSLTLGR	SPTBN4	2271	Q9H254
HELAEGSTADVLHSR	VPS13C	2691	Q709C8
RSIDDIGHLIHEGLQ	TTC17	206	Q96AE7
FTNTLRELGHAEHEI	PKD2L1	621	Q9P0L9
RELGHAEHEITELTA	PKD2L1	626	Q9P0L9
NSDLSIHEKIHTGER	ZNF585A	226	Q6P3V2
EHAKARVDHGAEIIT	MAP2	1766	P11137
HGVEVVLAHLEAART	SH2D3C	771	Q8N5H7
EEGAHVLRCSHVTLE	TRAPPC10	721	P48553
AAHSAEGDVHTLLLI	TREX2	186	Q9BQ50
DVSQRLHIDEILSHS	TSSK2	256	Q96PF2
HTSIVDLIEHSIRDS	SOCS6	451	O14544
ESRSHHLLGLEAVDR	TBC1D2	586	Q9BYX2
AETVVDVELHRHSLG	YEATS2	321	Q9ULM3
LDAGSHVADHLIVIL	UNC79	2441	Q9P2D8
EILHVHFATERATGV	WNK3	816	Q9BYP7
DTLHGDIIQLVHSSR	MYO7A	571	Q13402
SELAHLEEDVHLARS	MYOM2	106	P54296